MARKET INTRODUCTION
An antivirals drugs is a class of medication that is used specifically for treating the viral infection rather than the bacterial ones. Most of the antivirals are used for some specific viral infection whereas broad-spectrum antivirals is effective against the wide range of viruses. Like antibiotic specific antivirals are used for specific viruses. If you have been suffering from fever, an antiviral drug may be about 70% to 90% effective in preventing illness. Most antibiotics, antiviral drugs do not destroy their target pathogen instead they inhibit their development.
MARKET DYNAMICS
The antivirals market is anticipated to grow in the market by the advancement of new technologies. In addition, with rising demand for these devices is the key application for the growth of the industry. However, there is less awareness about this new device in the market. Furthermore, it has a superior ability to cut and seal and is rising demand in the forecast period. It has increased demand for minimally invasive surgeries that has the opportunity for market growth.
MARKET SCOPE
The "Antivirals Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in antivirals market with detailed market segmentation by drug type, therapeutics, end user, target and geography. The antivirals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in antivirals market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The antivirals market is segmented on the basis of drug type, therapeutics, end user and target. Based on drug type the market is segmented as generic and branded. On the basis of end user the market is categorized as hospitals, clinics and ambulatory surgical centers (ASCs). On the basis of therapeutics the market is categorized as HIV/AIDS therapeutics, hepatitis (B & C) therapeutics, herpes therapeutics, influenza therapeutics and others (pneumonia). On the basis of target the market is categorized as DNA polymerase, NS3 protease, reverse transcriptase and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in antivirals market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antivirals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting antivirals market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antivirals market in these regions.
MARKET PLAYERS
The report covers key developments in the in antivirals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in antivirals market are anticipated to have lucrative growth opportunities in the future with the rising demand for in antivirals market in the global market. Below mentioned is the list of few companies engaged in the Antivirals market.
The report also includes the profiles of key in antivirals market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Boehringer Ingelheim GmbH
- Bristol-Myers-Squibb
- Broad Institute
- F. Hoffmann-La Roche
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Mylan N.V
- Novartis AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Antivirals Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Abbott Laboratories
2. Boehringer Ingelheim GmbH
3. Bristol-Myers-Squibb
4. Broad Institute
5. F. Hoffmann-La Roche
6. GlaxoSmithKline plc.
7. Johnson & Johnson Services, Inc.
8. Merck & Co., Inc.
9. Mylan N.V
10. Novartis AG
1. Abbott Laboratories
2. Boehringer Ingelheim GmbH
3. Bristol-Myers-Squibb
4. Broad Institute
5. F. Hoffmann-La Roche
6. GlaxoSmithKline plc.
7. Johnson & Johnson Services, Inc.
8. Merck & Co., Inc.
9. Mylan N.V
10. Novartis AG